Список литературы

1. Means R.T. Pure red cell aplasia//Blood. 2016. Vol. 128, N 21.

2. Means R.T. Pure red cell aplasia: The second hundred years//American Journal of the Medical Sciences. 2023. Vol. 366, N 3.

3. Narla A., Lipton J.M., Means R.T. Red cell aplasia: Acquired and congenital disorders//Wintrobe's Clinical Hematology: Fourteenth Edition. 2018.

4. Ruggero D., Shimamura A. Marrow failure: A window into ribosome biology//Blood. 2014. Vol. 124, N 18.

5. Frickhofen N. et al. Parvovirus B19 as a cause of acquired chronic pure red cell aplasia//Br J Haematol. 1994. Vol. 87, N 4.

6. Brown K.E. et al. Resistance to Parvovirus B19 Infection Due to Lack of Virus Receptor (Erythrocyte P Antigen)//New England Journal of Medicine. 1994. Vol. 330, N 17.

7. Жукова Л.Ю. Х.А.В., К.О.Л., С.Н.Е., Т.А.Н. Транзиторная эритробластопения детского возраста: обзор 39 случаев//Педиатр. 2015. Vol. 6, N 15. P. 44 - 53.

8. Sawada K., Fujishima N., Hirokawa M. Acquired pure red cell aplasia: Updated review of treatment//British Journal of Haematology. 2008. Vol. 142, N 4.

9. Gurnari C., Maciejewski J.P. How I manage acquired pure red cell aplasia in adults//Blood. 2021. Vol. 137, N 15.

10. Lobbes H. et al. Pure red cell aplasia in systemic lupus erythematosus, a nationwide retrospective cohort and review of the literature//Rheumatology (United Kingdom). 2022. Vol. 61, N 1.

11. Aung F.M. et al. Incidence and natural history of pure red cell aplasia in major ABO-mismatched haematopoietic cell transplantation//Br J Haematol. 2013. Vol. 160, N 6.

12. Masuda M. et al. Clonal T cells of pure red-cell aplasia//Am J Hematol. 2005. Vol. 79, N 4.

13. Visco C. et al. Autoimmune cytopenias in chronic lymphocytic leukemia//American Journal of Hematology. 2014. Vol. 89, N 11.

14. Fujishima N. et al. Long-term responses and outcomes following immunosuppressive therapy in large granular lymphocyte leukemia-associated pure red cell aplasia: A Nationwide Cohort Study in Japan for the PRCA Collaborative Study Group//Haematologica. 2008. Vol. 93, N 10.

15. Mijovic A. et al. Chronic myeloid leukemia associated with pure red cell aplasia and terminating in promyelocytic transformation//Am J Hematol. 1989. Vol. 31, N 2.

16. Bernard C. et al. Thymoma associated with autoimmune diseases: 85 cases and literature review//Autoimmunity Reviews. 2016. Vol. 15, N 1.

17. Carson K.R. et al. Clinical characteristics of erythropoietin-associated pure red cell aplasia//Best Practice and Research: Clinical Haematology. 2005. Vol. 18, N 3 SPEC. ISS.

18. Choudry M.A., Moffett B.K., Laber D.A. Pure red-cell aplasia secondary to pregnancy, characterization of a syndrome//Ann Hematol. 2007. Vol. 86, N 4.

19. Nakazawa H. et al. Incidence of acquired pure red cell aplasia: a nationwide epidemiologic analysis with 2 registry databases in Japan//Blood Adv. 2022. Vol. 6, N 24.

20. Balasubramanian S.K. et al. Rational management approach to pure red cell aplasia//Haematologica. 2018. Vol. 103, N 2.

21. Masaoka A. et al. Thymomas associated with pure red cell aplasia. Histologic and follow-up studies//Cancer. 1989. Vol. 64, N 9.

22. Seifi S. et al. Thymoma recurrence and its predisposing factors in Iranian population: A single center study//Tanaffos. 2019. Vol. 18, N 4.

23. Hishida T. et al. Clinical features and prognostic impact of coexisting autoimmune disease other than myasthenia gravis in resected thymomas: Analysis of a Japanese multi-institutional retrospective database//European Journal of Cardio-thoracic Surgery. 2021. Vol. 59, N 3.

24. Maggi G. et al. Thymoma: Results of 241 operated cases//The Annals of Thoracic Surgery. 1991. Vol. 51, N 1.

25. Qiu Z.Y. et al. Methotrexate therapy of T-cell large granular lymphocytic leukemia impact of STAT3 mutation//Oncotarget. 2016. Vol. 7, N 38.

26. Kawahara S. et al. Clinical analysis of 52 patients with granular lymphocyte proliferative disorder (GLPD) showed frequent anemia in indolent T-cell GLPD in Japan//Eur J Haematol. 2009. Vol. 82, N 4.

27. Kwong Y.L. et al. T-cell large granular lymphocyte leukemia: An Asian perspective//Annals of Hematology. 2010. Vol. 89, N 4.

28. Hampel P.J. et al. Autoimmune cytopenias in patients with chronic lymphocytic leukaemia treated with ibrutinib in routine clinical practice at an academic medical centre//Br J Haematol. 2018. Vol. 183, N 3.

29. Tsang M. et al. Pure Red Cell Aplasia (PRCA) in Chronic Lymphocytic Leukemia (CLL): Etiology, Therapy, and Outcomes//Blood. 2015. Vol. 126, N 23.

30. Longval T. et al. Treatment for pure red cell aplasia after major ABO-incompatible allogeneic stem cell transplantation: a multicentre study//Br J Haematol. 2021. Vol. 193, N 4.

31. World Health Organization. ICD-10: international statistical classification of diseases and related health problems: tenth revision. 2nd ed. Geneva PP - Geneva: World Health Organization.

32. Petrenko A.A. et al. Pure red cell aplasia of the bone marrow in combination with thymoma. A literature review and own data//Ter Arkh. 2019. Vol. 91, N 7.

33. Shimizu R. et al. Efficacy and safety of oral deferasirox treatment for transfusional iron overload in pure red cell aplasia patients after allogeneic stem cell transplantation//Annals of Hematology. 2019. Vol. 98, N 7.

34. Hevessy Z. et al. Algorithm of differential diagnosis of anemia involving laboratory medicine specialists to advance diagnostic excellence//Clin Chem Lab Med. 2024. Vol. 62, N 3.

35. Soma P., Ellemdin S., Mashoeshoe K.S. The differential diagnosis of HIV related anaemia should include pure red cell aplasia//HIV and AIDS Review. 2013. Vol. 12, N 4.

36. Teague D. et al. Hepatitis C Infection Associated with Acquired Pure Red Cell Aplasia//Trop Med Infect Dis. 2023. Vol. 8, N 1.

37. Fu R. et al. The clinical characteristics and therapy response of patients with acquired pure red cell aplasia//Hematology. 2018. Vol. 23, N 9.

38. Pivnik A. V. et al. Pure red cell aplasia with M-gradient: A literature review and clinical experience//Klinicheskaya Onkogematologiya/Clinical Oncohematology. 2018. Vol. 11, N 3.

39. Zhu P. et al. Prevalence of Pure Red Cell Aplasia Following Major ABO-Incompatible Hematopoietic Stem Cell Transplantation//Front Immunol. 2022. Vol. 13.

40. Shokrgozar N., Tamaddon G. ABO blood grouping mismatch in hematopoietic stem cell transplantation and clinical guides//International Journal of Hematology-Oncology and Stem Cell Research. 2018. Vol. 12, N 4.

41. Charles R.J. et al. The pathophysiology of pure red cell aplasia: Implications for therapy//Blood. 1996. Vol. 87, N 11.

42. Lacy M.Q., Kurtin P.J., Tefferi A. Pure red cell aplasia: Association with large granular lymphocyte leukemia and the prognostic value of cytogenetic abnormalities//Blood. 1996. Vol. 87, N 7.

43. Crabol Y. et al. Intravenous immunoglobulin therapy for pure red cell aplasia related to human parvovirus B19 infection: A retrospective study of 10 patients and review of the literature//Clinical Infectious Diseases. 2013. Vol. 56, N 7.

44. Thompson D.F., Gales M.A. Drug-Induced Pure Red Cell Aplasia//Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 1996. Vol. 16, N 6.

45. Mouthon L., Guillevin L., Tellier Z. Intravenous immunoglobulins in autoimmune- or parvovirus B19-mediated pure red-cell aplasia//Autoimmunity Reviews. 2005. Vol. 4, N 5.

46. Kurhade K. et al. Multiple modalities in treating pediatric pure red cell aplasia: A case series//Pediatric Hematology Oncology Journal. 2023. Vol. 8, N 3.

47. Lobbes H. et al. Treatment strategy for acquired pure red cell aplasia: a systematic review and meta-analysis//Blood Advances. 2023. Vol. 7, N 21.

48. Biswal N., Narayanan P., Chetan G. Cyclosporine A responsive pure red cell aplasia in a child with systemic lupus erythematosus//Indian Journal of Hematology and Blood Transfusion. 2007. Vol. 23, N 3-4.

49. Long Z. et al. Successful treatment of refractory/relapsed acquired pure red cell aplasia with sirolimus//Ann Hematol. 2018. Vol. 97, N 11.

50. Huang Y. et al. Sirolimus is effective for refractory/relapsed/intolerant acquired pure red cell aplasia: results of a prospective single-institutional trial//Leukemia. 2022. Vol. 36, N 5.

51. Yang Y. et al. Sirolimus versus cyclosporine A in patients with primary acquired pure red cell aplasia: a prospective cohort study//Blood Cancer Journal. 2023. Vol. 13, N 1.

52. Salama Y. et al. Isolated anemia in patients with large granular lymphocytic leukemia (LGLL)//Blood Cancer J. 2022. Vol. 12, N 2.

53. Ghazal H. Successful treatment of pure red cell aplasia with rituximab in patients with chronic lymphocytic leukemia//Blood. 2002. Vol. 99, N 3.

54. Khan F. et al. Subcutaneous bortezomib is highly effective for pure red cell aplasia after ABO-incompatible haematopoietic stem cell transplantation//Transfusion Medicine. 2014. Vol. 24, N 3.

55. Harris S.I., Weinberg J.B. Treatment of red cell aplasia with antithymocyte globulin: Repeated inductions of complete remissions in two patients//Am J Hematol. 1985. Vol. 20, N 2.

56. Gomez-Arteaga A. et al. Use of anti-thymocyte globulin (ATG) for the treatment of pure red cell aplasia and immune-mediated cytopenias after allogeneic hematopoietic cell transplantation: a case series//Bone Marrow Transplantation. 2020. Vol. 55, N 12.

57. Mangla A H.H. Pure red cell aplasia//Treasure Island, FL: FL: StatPearls Publishing. 2021.

58. Passweg J.R., Rabusin M. Hematopoetic stem cell transplantation for immune thrombocytopenia and other refractory autoimmune cytopenias//Autoimmunity. 2008. Vol. 41, N 8.

59. Halkes C. et al. Allogeneic stem cell transplantation for acquired pure red cell aplasia//American Journal of Hematology. 2019. Vol. 94, N 11.

60. Кузьмина Л.А. Петинати Н.А. Л.Л.С. и др. Применение избирательной сорбции изогемагглютининов альфа у больной парциальной красноклеточной аплазией после трансплантации аллогенного костного мозга//Гематология и трансфузиология. 2011. P. 40 - 44.

61. Dellacasa C.M. et al. Efficacy of plasmapheresis for the treatment of pure red blood cell aplasia after allogeneic stem cell transplantation//Transfusion (Paris). 2015. Vol. 55, N 12.

62. Zhidong W., Hongmin Y., Hengxiang W. Successful treatment of pure red cell aplasia with a single low dose of rituximab in two patients after major ABO incompatible peripheral blood allogeneic stem cell transplantation//Transfusion Medicine. 2012. Vol. 22, N 4.

63. Busca A. et al. Eltrombopag for the Treatment of Refractory Pure RBC Aplasia after Major ABO Incompatible Hematopoietic Stem Cell Transplantation//Biology of Blood and Marrow Transplantation. 2018. Vol. 24, N 8.

64. Rautenberg C. et al. Daratumumab for treatment of pure red cell aplasia after allogeneic stem cell transplantation//Bone Marrow Transplantation. 2020. Vol. 55, N 6.

65. Martino R., I., Esquirol A. Daratumumab may be the most effective treatment for post-engraftment pure red cell aplasia due to persistent anti-donor isohemagglutinins after major ABO-mismatched allogeneic transplantation//Bone Marrow Transplantation. 2022. Vol. 57, N 2.

66. Verholen F. et al. Resistant pure red cell aplasia after allogeneic stem cell transplantation with major ABO mismatch treated by escalating dose donor leukocyte infusion//Eur J Haematol. 2004. Vol. 73, N 6.

67. Marco-Ayala J. et al. Pure red cell aplasia after major or bidirectional ABO incompatible hematopoietic stem cell transplantation: to treat or not to treat, that is the question//Bone Marrow Transplantation. 2021. Vol. 56, N 4.

68. Thompson C.A., Steensma D.P. Pure red cell aplasia associated with thymoma: Clinical insights from a 50-year single-institution experience//Br J Haematol. 2006. Vol. 135, N 3.

69. Yen C.C. et al. Pure Red Cell Aplasia and Other Haematological Diseases Associated With Thymoma: A Case Series and Systematic Review//Front Med (Lausanne). 2021. Vol. 8.

70. Moriyama S. et al. Pure red cell aplasia associated with thymoma: A report of a single-center experience//J Thorac Dis. 2018. Vol. 10, N 8.

71. Камельских Д. В К.М.Е. Подбор компонентов донорской крови в случае трансплантации аллогенного костного мозга и/или аллогенных гемопоэтических стволовых клеток//Гематология и трансфузиология. 2022. P. 112 - 113.

72. Carreras E D.C.M.M.K.N. (editors). The EBMT Handbook: Hematopoietic Stem Cell Transplantation and Cellular Therapies, 7th edition. Cham (CH): Springer. 2019. 163 - 169 p.